Biofrontera
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $9,012 | $7,839 | $7,901 | $10,596 |
Gross Profit | 4,211 | 3,497 | 3,955 | 4,933 |
EBITDA | -4,960 | 692 | -8,708 | 4,048 |
EBIT | -5,272 | 383 | -9,015 | 3,753 |
Net Income | -5,669 | -257 | -10,437 | 3,526 |
Net Change In Cash | 9,012 | 7,839 | 7,901 | 10,596 |
Free Cash Flow | -1,158 | -4,722 | -3,382 | -8,857 |
Cash | 2,873 | 4,379 | 3,817 | 1,343 |
Basic Shares | 5,773 | 5,091 | 3,623 | 2,140 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $34,071 | $28,674 | $24,100 | $18,849 |
Gross Profit | 16,627 | 13,489 | 11,358 | 9,783 |
EBITDA | -18,453 | 934 | -36,757 | -7,492 |
EBIT | -19,517 | -238 | -37,297 | -8,054 |
Net Income | -20,131 | -640 | -37,713 | -10,987 |
Net Change In Cash | 34,071 | 28,674 | 24,100 | 18,849 |
Free Cash Flow | -24,900 | -16,237 | -26,726 | -12,369 |
Cash | 1,343 | 17,208 | 24,545 | 8,080 |
Basic Shares | 1,546 | 1,056 | 855 | 580 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.81 |
2024-06-30 | -$0.05 |
2024-03-31 | -$2.88 |
2023-12-31 | $1.65 |
